Heart Failure Symptom Biology in Response to Ventricular Assist Device Implantation

Christopher S. Lee, James O. Mudd, Karen S. Lyons, Quin E. Denfeld, Corrine Y. Jurgens, Bradley Aouizerat, Jill M. Gelow, Christopher V. Chien, Emily Aarons, Kathleen L. Grady

Research output: Contribution to journalArticle

Abstract

BACKGROUND: We have a limited understanding of the biological underpinnings of symptoms in heart failure (HF), particularly in response to left ventricular assist device (LVAD) implantation. OBJECTIVE: The aim of this study was to quantify the degree to which symptoms and biomarkers change in parallel from before implantation through the first 6 months after LVAD implantation in advanced HF. METHODS: This was a prospective cohort study of 101 patients receiving an LVAD for the management of advanced HF. Data on symptoms (dyspnea, early and subtle symptoms [HF Somatic Perception Scale], pain severity [Brief Pain Inventory], wake disturbance [Epworth Sleepiness Scale], depression [Patient Health Questionnaire], and anxiety [Brief Symptom Inventory]) and peripheral biomarkers of myocardial stretch, systemic inflammation, and hypervolumetric mechanical stress were measured before implantation with a commercially available LVAD and again at 30, 90, and 180 days after LVAD implantation. Latent growth curve and parallel process modeling were used to describe changes in symptoms and biomarkers and the degree to which they change in parallel in response to LVAD implantation. RESULTS: In response to LVAD implantation, changes in myocardial stretch were closely associated with changes in early and subtle physical symptoms as well as depression, and changes in hypervolumetric stress were closely associated with changes in pain severity and wake disturbances. Changes in systemic inflammation were not closely associated with changes in physical or affective symptoms in response to LVAD implantation. CONCLUSIONS: These findings provide new insights into the many ways in which symptoms and biomarkers provide concordant or discordant information about LVAD response.

Original languageEnglish (US)
Pages (from-to)174-182
Number of pages9
JournalThe Journal of cardiovascular nursing
Volume34
Issue number2
DOIs
StatePublished - Mar 1 2019

Fingerprint

Heart-Assist Devices
Heart Failure
Biomarkers
Depression
Inflammation
Pain
Equipment and Supplies
Mechanical Stress
Pain Perception
Affective Symptoms
Dyspnea
Cohort Studies
Anxiety
Prospective Studies
Health

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Advanced and Specialized Nursing

Cite this

Heart Failure Symptom Biology in Response to Ventricular Assist Device Implantation. / Lee, Christopher S.; Mudd, James O.; Lyons, Karen S.; Denfeld, Quin E.; Jurgens, Corrine Y.; Aouizerat, Bradley; Gelow, Jill M.; Chien, Christopher V.; Aarons, Emily; Grady, Kathleen L.

In: The Journal of cardiovascular nursing, Vol. 34, No. 2, 01.03.2019, p. 174-182.

Research output: Contribution to journalArticle

Lee, CS, Mudd, JO, Lyons, KS, Denfeld, QE, Jurgens, CY, Aouizerat, B, Gelow, JM, Chien, CV, Aarons, E & Grady, KL 2019, 'Heart Failure Symptom Biology in Response to Ventricular Assist Device Implantation', The Journal of cardiovascular nursing, vol. 34, no. 2, pp. 174-182. https://doi.org/10.1097/JCN.0000000000000552
Lee, Christopher S. ; Mudd, James O. ; Lyons, Karen S. ; Denfeld, Quin E. ; Jurgens, Corrine Y. ; Aouizerat, Bradley ; Gelow, Jill M. ; Chien, Christopher V. ; Aarons, Emily ; Grady, Kathleen L. / Heart Failure Symptom Biology in Response to Ventricular Assist Device Implantation. In: The Journal of cardiovascular nursing. 2019 ; Vol. 34, No. 2. pp. 174-182.
@article{733069503bb6402c8e989abfc7e82e1f,
title = "Heart Failure Symptom Biology in Response to Ventricular Assist Device Implantation",
abstract = "BACKGROUND: We have a limited understanding of the biological underpinnings of symptoms in heart failure (HF), particularly in response to left ventricular assist device (LVAD) implantation. OBJECTIVE: The aim of this study was to quantify the degree to which symptoms and biomarkers change in parallel from before implantation through the first 6 months after LVAD implantation in advanced HF. METHODS: This was a prospective cohort study of 101 patients receiving an LVAD for the management of advanced HF. Data on symptoms (dyspnea, early and subtle symptoms [HF Somatic Perception Scale], pain severity [Brief Pain Inventory], wake disturbance [Epworth Sleepiness Scale], depression [Patient Health Questionnaire], and anxiety [Brief Symptom Inventory]) and peripheral biomarkers of myocardial stretch, systemic inflammation, and hypervolumetric mechanical stress were measured before implantation with a commercially available LVAD and again at 30, 90, and 180 days after LVAD implantation. Latent growth curve and parallel process modeling were used to describe changes in symptoms and biomarkers and the degree to which they change in parallel in response to LVAD implantation. RESULTS: In response to LVAD implantation, changes in myocardial stretch were closely associated with changes in early and subtle physical symptoms as well as depression, and changes in hypervolumetric stress were closely associated with changes in pain severity and wake disturbances. Changes in systemic inflammation were not closely associated with changes in physical or affective symptoms in response to LVAD implantation. CONCLUSIONS: These findings provide new insights into the many ways in which symptoms and biomarkers provide concordant or discordant information about LVAD response.",
author = "Lee, {Christopher S.} and Mudd, {James O.} and Lyons, {Karen S.} and Denfeld, {Quin E.} and Jurgens, {Corrine Y.} and Bradley Aouizerat and Gelow, {Jill M.} and Chien, {Christopher V.} and Emily Aarons and Grady, {Kathleen L.}",
year = "2019",
month = "3",
day = "1",
doi = "10.1097/JCN.0000000000000552",
language = "English (US)",
volume = "34",
pages = "174--182",
journal = "Journal of Cardiovascular Nursing",
issn = "0889-4655",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Heart Failure Symptom Biology in Response to Ventricular Assist Device Implantation

AU - Lee, Christopher S.

AU - Mudd, James O.

AU - Lyons, Karen S.

AU - Denfeld, Quin E.

AU - Jurgens, Corrine Y.

AU - Aouizerat, Bradley

AU - Gelow, Jill M.

AU - Chien, Christopher V.

AU - Aarons, Emily

AU - Grady, Kathleen L.

PY - 2019/3/1

Y1 - 2019/3/1

N2 - BACKGROUND: We have a limited understanding of the biological underpinnings of symptoms in heart failure (HF), particularly in response to left ventricular assist device (LVAD) implantation. OBJECTIVE: The aim of this study was to quantify the degree to which symptoms and biomarkers change in parallel from before implantation through the first 6 months after LVAD implantation in advanced HF. METHODS: This was a prospective cohort study of 101 patients receiving an LVAD for the management of advanced HF. Data on symptoms (dyspnea, early and subtle symptoms [HF Somatic Perception Scale], pain severity [Brief Pain Inventory], wake disturbance [Epworth Sleepiness Scale], depression [Patient Health Questionnaire], and anxiety [Brief Symptom Inventory]) and peripheral biomarkers of myocardial stretch, systemic inflammation, and hypervolumetric mechanical stress were measured before implantation with a commercially available LVAD and again at 30, 90, and 180 days after LVAD implantation. Latent growth curve and parallel process modeling were used to describe changes in symptoms and biomarkers and the degree to which they change in parallel in response to LVAD implantation. RESULTS: In response to LVAD implantation, changes in myocardial stretch were closely associated with changes in early and subtle physical symptoms as well as depression, and changes in hypervolumetric stress were closely associated with changes in pain severity and wake disturbances. Changes in systemic inflammation were not closely associated with changes in physical or affective symptoms in response to LVAD implantation. CONCLUSIONS: These findings provide new insights into the many ways in which symptoms and biomarkers provide concordant or discordant information about LVAD response.

AB - BACKGROUND: We have a limited understanding of the biological underpinnings of symptoms in heart failure (HF), particularly in response to left ventricular assist device (LVAD) implantation. OBJECTIVE: The aim of this study was to quantify the degree to which symptoms and biomarkers change in parallel from before implantation through the first 6 months after LVAD implantation in advanced HF. METHODS: This was a prospective cohort study of 101 patients receiving an LVAD for the management of advanced HF. Data on symptoms (dyspnea, early and subtle symptoms [HF Somatic Perception Scale], pain severity [Brief Pain Inventory], wake disturbance [Epworth Sleepiness Scale], depression [Patient Health Questionnaire], and anxiety [Brief Symptom Inventory]) and peripheral biomarkers of myocardial stretch, systemic inflammation, and hypervolumetric mechanical stress were measured before implantation with a commercially available LVAD and again at 30, 90, and 180 days after LVAD implantation. Latent growth curve and parallel process modeling were used to describe changes in symptoms and biomarkers and the degree to which they change in parallel in response to LVAD implantation. RESULTS: In response to LVAD implantation, changes in myocardial stretch were closely associated with changes in early and subtle physical symptoms as well as depression, and changes in hypervolumetric stress were closely associated with changes in pain severity and wake disturbances. Changes in systemic inflammation were not closely associated with changes in physical or affective symptoms in response to LVAD implantation. CONCLUSIONS: These findings provide new insights into the many ways in which symptoms and biomarkers provide concordant or discordant information about LVAD response.

UR - http://www.scopus.com/inward/record.url?scp=85061291898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061291898&partnerID=8YFLogxK

U2 - 10.1097/JCN.0000000000000552

DO - 10.1097/JCN.0000000000000552

M3 - Article

VL - 34

SP - 174

EP - 182

JO - Journal of Cardiovascular Nursing

JF - Journal of Cardiovascular Nursing

SN - 0889-4655

IS - 2

ER -